Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC
Clinical trial NCT05011487 · RECRUITING
Trial details
- NCT number
- NCT05011487
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-13
- Primary completion
- 2023-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.